You just read:

Emmaus Life Sciences Receives Notice of FDA PDUFA Date for Investigational L-glutamine Treatment for Sickle Cell Disease

News provided by

Emmaus Life Sciences, Inc.

29 Nov, 2016, 08:00 ET